Study of ONTAK in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL)

Clinical trial NCT00055146 · COMPLETED

Trial details

NCT number: NCT00055146
Sponsor: Eisai Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia, Lymphocytic, Chronic

Start date: 2003-03-01
Primary completion: 2006-03-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.